Fanghui ZHAO

Fanghui ZHAO, researcher. She has led her team to carry out a series of innovative research in the fields of cervical cancer etiology research, screening technology development and popularization, HPV vaccine clinical trials, and comprehensive prevention and treatment health policy, with her scientific achievements being of a leading international standard. Over the past twenty years, she has expounded on the natural history of the development of cervical cancer disease among women in China, identified the epidemiological characteristics of the HPV population, demonstrated the application value of screening technologies such as VIA/VILL liquid-based cytology and HPV DNA testing in China, evaluated the clinical effectiveness of on-market quadrivalent HPV vaccines as a principal investigator, and carried out cervical cancer prevention and elimination health policy research in line with the national strategy. She has also led her team in more than 50 international and domestic research projects, and as the head of the department and faculty, she has coordinated and managed research groups in molecular epidemiology, field epidemiology, clinical epidemiology, and health policy evaluation. She has been awarded the WHO/International Agency for Research on Cancer (IARC) Senior Visiting Scientist Award, the IARC “50 for 50” Future Cancer Research Leader, the APEC Health Women and Health Economy Research Prize Winner .